Sepiapterin

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 644 publications

Clinicopathologic mismatch in young-onset parkinsonism: Multiple system atrophy masquerading as a neurotransmitter synthesis disorder.

Clinicopathologic mismatch in young-onset parkinsonism: Multiple system atrophy masquerading as a neurotransmitter synthesis disorder.

Journal: Clinical neuropathology

Published: August 10, 2026

Sepiapterin: A Distinct, Dual Mechanism of Action that Leads to Potential Treatment Benefits Across the Spectrum of Phenylketonuria Disease Severities.

Sepiapterin: A Distinct, Dual Mechanism of Action that Leads to Potential Treatment Benefits Across the Spectrum of Phenylketonuria Disease Severities.

Journal: Advances in therapy

Published: June 06, 2026

Real-world experience with sepiapterin in phenylketonuria: A single-center retrospective analysis.

Real-world experience with sepiapterin in phenylketonuria: A single-center retrospective analysis.

Journal: Molecular genetics and metabolism

Published: April 02, 2026

Nutritional and Therapeutic Strategies in Paediatric Phenylketonuria: A Narrative Literature Review.

Nutritional and Therapeutic Strategies in Paediatric Phenylketonuria: A Narrative Literature Review.

Journal: Nutrients

Published: March 26, 2026

Cell type diversification and phenotype convergence underlying white fin-ornamentation of cyprinid fishes.

Cell type diversification and phenotype convergence underlying white fin-ornamentation of cyprinid fishes.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 24, 2026

AKR1C3-driven restoration of tetrahydrobiopterin synthesis in cellular sepiapterin reductase deficiency.

AKR1C3-driven restoration of tetrahydrobiopterin synthesis in cellular sepiapterin reductase deficiency.

Journal: Free radical biology & medicine

Published: March 12, 2026

Sepiapterin: From sapropterin to next-generation therapy.

Sepiapterin: From sapropterin to next-generation therapy.

Journal: Molecular genetics and metabolism

Published: February 06, 2026

Follow-up and outcome of patients with primary BH4 deficiencies.

Follow-up and outcome of patients with primary BH4 deficiencies.

Journal: Frontiers in neurology

Published: January 21, 2026

Targeted endothelial GTPCH1/BH4 pathway activation reverses vascular dysfunction in smoking-associated obesity.

Targeted endothelial GTPCH1/BH4 pathway activation reverses vascular dysfunction in smoking-associated obesity.

Journal: Biochemical pharmacology

Published: January 15, 2026

The genetics, evolution, and maintenance of a biological rock-paper-scissors game.

The genetics, evolution, and maintenance of a biological rock-paper-scissors game.

Journal: Science (New York, N.Y.)

Published: January 01, 2026

Ethnic Bridging of Sepiapterin in Chinese and Korean Populations Based on Predictions From Genetic Polymorphism of Breast Cancer Resistance Protein.

Ethnic Bridging of Sepiapterin in Chinese and Korean Populations Based on Predictions From Genetic Polymorphism of Breast Cancer Resistance Protein.

Journal: Clinical and translational science

Published: December 16, 2025

Sepiapterin as a treatment for people living with phenylketonuria: a plain language summary of the APHENITY trial.

Sepiapterin as a treatment for people living with phenylketonuria: a plain language summary of the APHENITY trial.

Journal: Journal of comparative effectiveness research

Published: December 09, 2025

Showing 1-12 of 644

Last Updated: 09/26/2026